| pubmed-article:9299854 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9299854 | lifeskim:mentions | umls-concept:C0029921 | lld:lifeskim |
| pubmed-article:9299854 | lifeskim:mentions | umls-concept:C0040038 | lld:lifeskim |
| pubmed-article:9299854 | lifeskim:mentions | umls-concept:C0348013 | lld:lifeskim |
| pubmed-article:9299854 | lifeskim:mentions | umls-concept:C0231220 | lld:lifeskim |
| pubmed-article:9299854 | lifeskim:mentions | umls-concept:C0019116 | lld:lifeskim |
| pubmed-article:9299854 | lifeskim:mentions | umls-concept:C1707391 | lld:lifeskim |
| pubmed-article:9299854 | lifeskim:mentions | umls-concept:C0439661 | lld:lifeskim |
| pubmed-article:9299854 | lifeskim:mentions | umls-concept:C0243077 | lld:lifeskim |
| pubmed-article:9299854 | lifeskim:mentions | umls-concept:C0205296 | lld:lifeskim |
| pubmed-article:9299854 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:9299854 | pubmed:dateCreated | 1997-10-6 | lld:pubmed |
| pubmed-article:9299854 | pubmed:abstractText | Deficiencies of natural inhibitors and the presence of lupus anticoagulant are important risk factors leading to venous thromboembolic events. Before resistance to activated protein C (APC-R) was identified, the overall prevalence of inherited abnormalities of hemostasis in non-selected outpatients with venous thromboembolic disease was under 10%. This cast doubts on the of cost effectiveness and clinical significance of assaying hemostasis inhibitors in all such patients. The goal of this study is to evaluate the prevalence of inherited and acquired abnormalities of hemostasis in younger symptomatic outpatients with objectively diagnosed venous thromboembolic disease (VTD). | lld:pubmed |
| pubmed-article:9299854 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9299854 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9299854 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9299854 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9299854 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9299854 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9299854 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9299854 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9299854 | pubmed:issn | 0390-6078 | lld:pubmed |
| pubmed-article:9299854 | pubmed:author | pubmed-author:PileriAA | lld:pubmed |
| pubmed-article:9299854 | pubmed:author | pubmed-author:AluffiEE | lld:pubmed |
| pubmed-article:9299854 | pubmed:author | pubmed-author:RabbiaCC | lld:pubmed |
| pubmed-article:9299854 | pubmed:author | pubmed-author:BorchielliniA... | lld:pubmed |
| pubmed-article:9299854 | pubmed:author | pubmed-author:BazzaoLL | lld:pubmed |
| pubmed-article:9299854 | pubmed:author | pubmed-author:TamponiGG | lld:pubmed |
| pubmed-article:9299854 | pubmed:author | pubmed-author:PannocchiaAA | lld:pubmed |
| pubmed-article:9299854 | pubmed:author | pubmed-author:SchincoPP | lld:pubmed |
| pubmed-article:9299854 | pubmed:author | pubmed-author:VaccarinoAA | lld:pubmed |
| pubmed-article:9299854 | pubmed:author | pubmed-author:MontaruliBB | lld:pubmed |
| pubmed-article:9299854 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9299854 | pubmed:volume | 82 | lld:pubmed |
| pubmed-article:9299854 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9299854 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9299854 | pubmed:pagination | 420-2 | lld:pubmed |
| pubmed-article:9299854 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:9299854 | pubmed:meshHeading | pubmed-meshheading:9299854-... | lld:pubmed |
| pubmed-article:9299854 | pubmed:meshHeading | pubmed-meshheading:9299854-... | lld:pubmed |
| pubmed-article:9299854 | pubmed:meshHeading | pubmed-meshheading:9299854-... | lld:pubmed |
| pubmed-article:9299854 | pubmed:meshHeading | pubmed-meshheading:9299854-... | lld:pubmed |
| pubmed-article:9299854 | pubmed:meshHeading | pubmed-meshheading:9299854-... | lld:pubmed |
| pubmed-article:9299854 | pubmed:meshHeading | pubmed-meshheading:9299854-... | lld:pubmed |
| pubmed-article:9299854 | pubmed:meshHeading | pubmed-meshheading:9299854-... | lld:pubmed |
| pubmed-article:9299854 | pubmed:meshHeading | pubmed-meshheading:9299854-... | lld:pubmed |
| pubmed-article:9299854 | pubmed:meshHeading | pubmed-meshheading:9299854-... | lld:pubmed |
| pubmed-article:9299854 | pubmed:meshHeading | pubmed-meshheading:9299854-... | lld:pubmed |
| pubmed-article:9299854 | pubmed:meshHeading | pubmed-meshheading:9299854-... | lld:pubmed |
| pubmed-article:9299854 | pubmed:articleTitle | Natural and acquired inhibitors of hemostasis in selected symptomatic outpatients with venous thromboembolic disease. | lld:pubmed |
| pubmed-article:9299854 | pubmed:affiliation | Department of Hematology and Onco-Hematology, University of Turin, Italy. | lld:pubmed |
| pubmed-article:9299854 | pubmed:publicationType | Journal Article | lld:pubmed |
